SALEM INVESTMENT COUNSELORS INC - CELLDEX THERAPEUTICS INC NEW ownership

CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 165 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q3 2015. The put-call ratio across all filers is 4.61 and the average weighting 0.1%.

Quarter-by-quarter ownership
SALEM INVESTMENT COUNSELORS INC ownership history of CELLDEX THERAPEUTICS INC NEW
ValueSharesWeighting
Q4 2017$1,0000.0%5000.0%0.00%
Q3 2017$1,000
-66.7%
500
-52.4%
0.00%
Q2 2017$3,000
-25.0%
1,0500.0%0.00%
Q4 2016$4,000
-90.5%
1,0500.0%0.00%
-100.0%
Q3 2016$42,000
-61.1%
1,050
-95.7%
0.00%
-92.3%
Q2 2016$108,000
+13.7%
24,500
-2.0%
0.01%
+8.3%
Q1 2016$95,000
-75.3%
25,000
+2.0%
0.01%
-75.5%
Q4 2015$384,000
+69.2%
24,500
+12.7%
0.05%
+63.3%
Q3 2015$227,000
-59.2%
21,740
-1.4%
0.03%
-55.9%
Q2 2015$556,000
-14.2%
22,040
-5.2%
0.07%
-11.7%
Q1 2015$648,000
+52.8%
23,2400.0%0.08%
+51.0%
Q4 2014$424,000
-3.6%
23,240
-31.5%
0.05%
-3.8%
Q3 2014$440,000
-24.7%
33,940
-5.2%
0.05%
-25.4%
Q2 2014$584,000
-21.6%
35,790
-15.1%
0.07%
-22.8%
Q1 2014$745,000
-30.7%
42,140
-5.1%
0.09%
-34.3%
Q4 2013$1,075,000
-31.7%
44,4200.0%0.14%
-36.1%
Q3 2013$1,574,000
+127.1%
44,4200.0%0.22%
+119.0%
Q2 2013$693,00044,4200.10%
Other shareholders
CELLDEX THERAPEUTICS INC NEW shareholders Q3 2015
NameSharesValueWeighting ↓
Ridgeback Capital Investments L.P. 1,025,000$24,815,00031.36%
TSP Capital Management Group, LLC 836,342$20,248,0008.80%
Iguana Healthcare Management, LLC 200,000$4,842,0002.76%
First Light Asset Management, LLC 116,096$2,811,0002.38%
SECTORAL ASSET MANAGEMENT INC 2,227,688$53,932,0002.33%
BENNETT LAWRENCE MANAGEMENT L L C/NY 550,735$13,334,0002.05%
Eventide Asset Management 257,000$6,222,0001.92%
Redmile Group, LLC 397,951$9,634,0001.19%
ARDSLEY ADVISORY PARTNERS LP 357,000$8,643,0001.15%
Rhenman & Partners Asset Management AB 90,000$2,179,0000.85%
View complete list of CELLDEX THERAPEUTICS INC NEW shareholders